Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
2019 · The Lancet · 2,820 citations
https://doi.org/10.1016/s0140-6736(19)31149-3
J
Jagdeesh Ullal
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
49
Papers
4.0K
Citations
14
h-index
17
i10-index
Jagdeesh Ullal is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Diabetes Management and Research & Hyperglycemia and glycemic control in critically ill and hospitalized patients & Diabetes and associated disorders. The author has an h-index of 14, co-authored 42 publications.
ORCID: 0000-0001-9378-8340Papers by this author
worksDulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
2019 · The Lancet · 600 citations
https://doi.org/10.1016/s0140-6736(19)31150-x
Cystic fibrosis related liver disease and endocrine considerations
2021 · Journal of Clinical & Translational Endocrinology · 15 citations
https://doi.org/10.1016/j.jcte.2021.100283
SGLT2 inhibitor therapy in overweight and obese patients with cystic fibrosis-related diabetes: Case series
2025 · Journal of Clinical & Translational Endocrinology · 0 citations
https://doi.org/10.1016/j.jcte.2025.100403
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat